Citations

Showing 10 of 108104 citations.

Mll‐COMPASS complexes mediate H3K4me3 enrichment and transcription of the osteoblast master gene Runx2/p57 in osteoblasts
Rojas, Adriana , Sepúlveda, Hugo , Henríquez, Berta, Aguilar, Rodrigo , Opazo, Tatiana , Nardocci, Gino , Bustos, Fernando J. , Lian, Jane B. , Stein, Janet L. , Stein, Gary S., Zundert, Brigitte van , Wijnen, André J. van , Allende, Miguel L. , Montecino, Martı́n , Bustos, Fernando , van Wijnen, Andre J

Mayo Clinic

Journal of Cellular Physiology | September 7, 2018 | Volume: 234 | Issue: 5 | Pages: 6244-6253

10.1002/jcp.27355 | PMID 30256410 Get It

Abstract Expression of Runx2/p57 is a hallmark of the osteoblast‐lineage identity. Although several regulators that control the expression of Runx2/p57 during osteoblast‐lineage commitment have been identified, the epigenetic mechanisms that sustain this expression in differentiated osteoblasts remain to be completely determined. Here, we assess epigenetic mechanisms associated with Runx2/p57 gene transcription in differentiating MC3T3 mouse osteoblasts. Our results show that an enrichment of activating histone marks at the Runx2/p57 P1 promoter is accompanied by the simultaneous interaction of Wdr5 and Utx proteins, both are components of COMPASS complexes. Knockdown of Wdr5 and Utx expression confirms the activating role of both proteins at the Runx2‐P1 promoter. Other chromatin modifiers that were previously described to regulate Runx2/p57 transcription in mesenchymal precursor cells (Ezh2, Prmt5, and Jarid1b proteins) were not found to contribute to Runx2/p57 transcription in full‐committed osteoblasts. We also determined the presence of additional components of COMPASS complexes at the Runx2/p57 promoter, evidencing that the Mll2/COMPASS‐ and Mll3/COMPASS‐like complexes bind to the P1 promoter in osteoblastic cells expressing Runx2/p57 to modulate the H3K4me1 to H3K4me3 transition.
Inside Cover: Fiber‐based fluorescence lifetime imaging of recellularization processes on vascular tissue constructs (J. Biophotonics 9/2018)
Alfonso‐García, Alba , Marcu, Laura , Marcu, Laura , Shklover, Jeny , Sherlock, Benjamin E. , Panitch, Alyssa , Griffiths, Leigh G.

Mayo Clinic

Journal of Biophotonics | September 7, 2018 | Volume: 11 | Issue: 9 | Pages: No page available

10.1002/jbio.201870158 Get It

Tissue autofluorescence provides fluorescence lifetime contrast between acellular tissue and that containing newly seeded cells. Fiber‐based fluorescence lifetime imaging (FLIm) can be used for tracking recellularization of engineered vascular grafts and potential matrix remodeling at large scale, without compromising sample integrity. FLIm cellular contrast was verified in a subset of samples seeded with eGFP‐labelled cells. Results suggests fiberbased FLIm is a suitable tool for monitoring recellularization of engineered tissue nondestructively.Further details can be found in the article by Alba Alfonso‐Garcia, Jeny Shklover, Benjamin E. Sherlock, et al. (e201700391). image
Cryptococcus neoformansinfections in patients with lymphoproliferative neoplasms
Dioverti, M. Veronica , Osmon, Douglas R. , Tande, Aaron J. , Dioverti, Maria V, Tande, Aaron , Dioverti, Maria Veronica , Parikh, Sameer A. , Habermann, Thomas M.

Mayo Clinic

Leukemia & Lymphoma | September 7, 2018 | Volume: 60 | Issue: 4 | Pages: 920-926

10.1080/10428194.2018.1508666 | PMID 30188226 Get It

Blaming the PFO in patients with cryptogenic ischaemic stroke: Round 2
Holmes, David R. , Alkhouli, Mohamad

Mayo Clinic

European Heart Journal | September 6, 2018 | Volume: 40 | Issue: 11 | Pages: 925-927

10.1093/eurheartj/ehy509 | PMID 30202875 Get It

Sex and gender in Alzheimer's disease – Does it matter?
Mielke, Michelle M. , Ferretti, Maria Teresa , Iulita, M. Florencia , Hayden, Kathleen, Khachaturian, Ara S. , Mielke, Michelle M

Mayo Clinic

Alzheimer's & Dementia | September 6, 2018 | Volume: 14 | Issue: 9 | Pages: 1101-1103

10.1016/j.jalz.2018.08.003 | PMID 30196887 Get It

Cochlear Implantation: An Overview
Deep, Nicholas L. , Dowling, Eric M. , Jethanamest, Daniel , Carlson, Matthew L. , Dowling, Eric

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | September 6, 2018 | Volume: 80 | Issue: 02 | Pages: 169-177

10.1055/s-0038-1669411 | PMID 30931225 Get It

AbstractA cochlear implant (CI) is a surgically implanted device for the treatment of severe to profound sensorineural hearing loss in children and adults. It works by transducing acoustic energy into an electrical signal, which is used to stimulate surviving spiral ganglion cells of the auditory nerve. The past 2 decades have witnessed an exponential rise in the number of CI surgeries performed. Continual developments in programming strategies, device design, and minimally traumatic surgical technique have demonstrated the safety and efficacy of CI surgery. As a result, candidacy guidelines have expanded to include both pre and postlingually deaf children as young as 1 year of age, and those with greater degrees of residual hearing. A growing proportion of patients are undergoing CI for off-label or nontraditional indications including single-sided deafness, retrocochlear hearing loss, asymmetrical sensorineural hearing loss (SNHL) in adults and children with at least 1 ear that is better than performance cut-off for age, and children less than 12 months of age. Herein, we review CI design, clinical evaluation, indications, operative technique, and outcomes. We also discuss the expanding indications for CI surgery as it relates to lateral skull base pathology, comparing CI to auditory brainstem implants, and address the concerns with obtaining magnetic resonance imaging (MRI) in CI recipients.
Theoretical and experimental analysis of photon counting detector CT for proton stopping power prediction
Taasti, Vicki Trier , Hansen, David C. , Michalak, Gregory J. , Deisher, A., Kruse, Jon J. , Muren, L.P. , Petersen, Jørgen B. B. , Deisher, Amanda J, McCollough, Cynthia H.

Mayo Clinic

Medical Physics | September 6, 2018 | Volume: 45 | Issue: 11 | Pages: 5186-5196

10.1002/mp.13173 | PMID 30191573 Get It

Purpose Photon counting detectors (PCDs) are being introduced in advanced x‐ray computed tomography (CT) scanners. From a single PCD‐CT acquisition, multiple images can be reconstructed, each based on only a part of the original x‐ray spectrum. In this study, we investigated whether PCD‐CT can be used to estimate stopping power ratios (SPRs) for proton therapy treatment planning, both by comparing to other SPR methods proposed for single energy CT (SECT) and dual energy CT (DECT) as well as to experimental measurements. Methods A previously developed DECT‐based SPR estimation method was adapted to PCD‐CT data, by adjusting the estimation equations to allow for more energy spectra. The method was calibrated directly on noisy data to increase the robustness toward image noise. The new PCD SPR estimation method was tested in theoretical calculations as well as in an experimental setup, using both four and two energy bin PCD‐CT images, and through comparison to two other SPR methods proposed for SECT and DECT. These two methods were also evaluated on PCD‐CT images, full spectrum (one‐bin) or two‐bin images, respectively. In a theoretical framework, we evaluated the effect of patient‐specific tissue variations (density and elemental composition) and image noise on the SPR accuracy; the latter effect was assessed by applying three different noise levels (low, medium, and high noise). SPR estimates derived using real PCD‐CT images were compared to experimentally measured SPRs in nine organic tissue samples, including fat, muscle, and bone tissues. Results For the theoretical calculations, the root‐mean‐square error (RMSE) of the SPR estimation was 0.1% for the new PCD method using both two and four energy bins, compared to 0.2% and 0.7% for the DECT‐ and SECT‐based method, respectively. The PCD method was found to be very robust toward CT image noise, with a RMSE of 2.7% when high noise was added to the CT numbers. Introducing tissue variations, the RMSE only increased to 0.5%; even when adding high image noise to the changed tissues, the RMSE stayed within 3.1%. In the experimental measurements, the RMSE over the nine tissue samples was 0.8% when using two energy bins, and 1.0% for the four‐bin images. Conclusions In all tested cases, the new PCD method produced similar or better results than the SECT‐ and DECT‐based methods, showing an overall improvement of the SPR accuracy. This study thus demonstrated that PCD‐CT scans will be a qualified candidate for SPR estimations.
Treatment Strategy of a Patient With a Brain Arteriovenous Malformation and Cranial Dural Fistula: 2-Dimensional Operative Video
Sattur, Mithun G. , Abi-Aad, Karl R., Tian, Fucheng, Welz, Matthew E., Anderies, Barrett J. , Anderies, Barrett, Bendok, Bernard R.

Mayo Clinic

Operative Neurosurgery | September 6, 2018 | Volume: 16 | Issue: 5 | Pages: 636-636

10.1093/ons/opy208 | PMID 30202995 Get It

Abstract We present the case of a 56-yr-old right-handed male, after informed consent was obtained, who presented with acute confusion and agitation, on the background of a remote history of an uncomplicated resection of a left parietal grade 2 glioma. Imaging revealed a large, acute right temporal intracerebral hemorrhage (ICH). Standard vascular workup for the cause of the ICH included catheter angiography. No direct cause of the hemorrhage was revealed; however, a high grade parasagittal dural arteriovenous fistula (DAVF) with cortical venous reflux was noted close to the prior craniotomy site. The venous reflux was towards the left hemisphere, but it was hypothesized that similar reflux on the right side may have been present and was not presently evident due to thrombosis. The DAVF was embolized by endovascular means, followed by evacuation of the hematoma. Follow-up angiogram 7 mo later revealed a high-flow, right superior temporal cortical arteriovenous malformation (AVM). The DAVF unfortunately had also progressed. Endovascular occlusion of both lesions was attempted but was not successful. Subsequently, microsurgical resection for both the vascular malformations was performed with careful pre- and intraoperative planning to obtain a successful clinical and angiographic result. In this video, we summarize diagnostic and therapeutic nuances that have broad implications for the workup of ICH and the strategic management of a unique scenario involving a brain AVM and high-grade cranial dural fistula in the same patient. Prior to each procedure, informed consent was obtained from the patient, which includes consent for publication.
Biomechanical Evaluation of Suture Anchor versus Transosseous Tunnel Patellar Tendon Repair Techniques
Sherman, Seth L. , Black, Brandee S., Mooberry, Matthew A., Freeman, Katie L., Gulbrandsen, Trevor R. , Milles, Jeffrey L., Evans, Laura , Flood, David, Mooberry, Matthew, Evans, Laura, Pfeiffer, Ferris M.

Mayo Clinic

The Journal of Knee Surgery | September 6, 2018 | Volume: 32 | Issue: 08 | Pages: 825-832

10.1055/s-0038-1669790 | PMID 30189438 Get It

Abstract The objective of this study is to compare the cyclic loading strength and ultimate failure load in suture anchor repair versus transosseous tunnel repair of patellar tendons using a cadaver model. Twelve cadaveric patella specimens were used (six matched pairs). Dual-energy X-ray absorptiometry (DXA) measurements were performed to ensure equal bone quality among groups. All right knees were assigned to the suture anchor repair group (n = 6), whereas all left knees were assigned to the transosseous bone tunnel group (n = 6). Suture type and repair configuration were equivalent. After the respective procedures were performed, each patella was mounted into a gripping jig. Tensile load was applied at a rate of 1 Hz between magnitudes of 50 and 150 N, 50 and 200 N, 50 and 250 N, and tensile load at a rate of 0.1 mm/s until failure. Failure was defined as a sharp deviation in the linear load versus displacement curve, and failure mode was recorded. DXA measurements demonstrated equivalence of bone quality between the two groups (p > 0.05). During cyclic load testing, there was only a statistically significant difference between the groups with regard to cyclic loading at the 50 to 200 N loading cycle (p = 0.010). There was no statistically significant difference between the groups with regard to ultimate load to failure (p = 0.43). Failure mode within the suture anchor cohort occurred through anchor pullout except for one, which failed through the tendon. All specimens within the transosseous cohort failed through the midsubstance of the tendon except for one, which failed through suture breakage. Suture anchor repair demonstrated a similar biomechanical profile regarding cyclic loading and ultimate load to failure when compared with “gold standard” transosseous tunnel patellar tendon repair with a trend toward less gapping in the suture anchor group. Using suture anchors for repair of the patella tendon has similar biomechanical properties to transpatellar tunnels but may provide other clinical advantages.
Thyroidectomy for Amiodarone-Induced Thyrotoxicosis: Mayo Clinic Experience
Kotwal, Anupam , Clark, Jennifer , Lyden, Melanie L. , McKenzie, Travis J. , Thompson, Geoffrey B. , Stan, Marius N. , Lyden, Melanie, McKenzie, Travis , Thompson, Geoffrey , Kudva, Yogish C , Stan, Marius N

Mayo Clinic

Journal of the Endocrine Society | September 6, 2018 | Volume: 2 | Issue: 11 | Pages: 1226-1235

10.1210/js.2018-00259 | PMID 30370394 Get It